# Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer

> **NCT03268993** · NA · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 6 (actual)

## Conditions studied

- Head and Neck Cancer
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Head and Neck Carcinoma
- Head and Neck
- Tobacco-Related Carcinoma
- Carcinoma in Situ
- Dysplasia
- Hyperplasia
- Premalignant Lesion

## Interventions

- **DIETARY_SUPPLEMENT:** Avmacol

## Key facts

- **NCT ID:** NCT03268993
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-27
- **Primary completion:** 2019-07-22
- **Final completion:** 2019-07-22
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2023-04-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03268993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03268993, "Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03268993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*